The Clinical Trial Disclosure Maturity Model: a Framework for Excellence
Article
薬事規制関連支援サービス
Article 2 in our Maturity Model series
Executive Summary
In today’s complex and highly regulated clinical trial landscape, ensuring robust disclosure and transparency practices is more critical than ever. As stakeholders demand greater access to clinical trial information, organizations must establish strong processes and governance structures to meet these expectations while maintaining compliance and efficiency. This is where the clinical trial disclosure maturity model comes into play.
About the author
Thomas Wicks
Head of Transparency Operations, Citeline
Thomas Wicks is an experienced strategic leader with over 20 years in life sciences. As Head of Transparency Operations at Citeline, he spearheads strategy for TrialScope's industry-leading disclosure solutions. Thomas is an established thought leader, having spoken at over 60 conferences and authored over 40 publications on disclosure requirements and transparency trends. Thomas is motivated by empowering teams to accelerate solutions that honor trial transparency.
